Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Duddy

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|November 8, 2021
Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019Gavin McCluskey, William Duddy, Stephen Haffey, et al.
Molecular Therapy. Nucleic Acids|November 16, 2018
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of DysferlinopathyJoshua J A Lee, Rika Maruyama, William Duddy, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin ExpressionJoshua J A Lee, Takashi Saito, William Duddy, et al.
Journal of Personalized Medicine|September 23, 2022
The Role of Sphingomyelin and Ceramide in Motor Neuron DiseasesGavin McCluskey, Colette Donaghy, Karen E Morrison, et al.
Life (Basel, Switzerland)|January 21, 2023
Extracellular Vesicles in Amyotrophic Lateral SclerosisGavin McCluskey, Karen E Morrison, Colette Donaghy, et al.
Plos One|May 18, 2018
Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblastsJoshua Lee, Yusuke Echigoya, William Duddy, et al.
International Journal of Molecular Sciences|February 25, 2023
Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALSChristina Vasilopoulou, Sarah L McDaid-McCloskey, Gavin McCluskey, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Changes in Communication between Muscle Stem Cells and their Environment with AgingMatthew Thorley, Apostolos Malatras, William Duddy, et al.
Cells|March 10, 2022
The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger SubtypesEkene Anakor, Vanessa Milla, Owen Connolly, et al.
Frontiers in Neurology|May 30, 2019
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALSUdaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|November 8, 2021
Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019Gavin McCluskey, William Duddy, Stephen Haffey, et al.
Molecular Therapy. Nucleic Acids|November 16, 2018
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of DysferlinopathyJoshua J A Lee, Rika Maruyama, William Duddy, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin ExpressionJoshua J A Lee, Takashi Saito, William Duddy, et al.
Journal of Personalized Medicine|September 23, 2022
The Role of Sphingomyelin and Ceramide in Motor Neuron DiseasesGavin McCluskey, Colette Donaghy, Karen E Morrison, et al.
Life (Basel, Switzerland)|January 21, 2023
Extracellular Vesicles in Amyotrophic Lateral SclerosisGavin McCluskey, Karen E Morrison, Colette Donaghy, et al.
Plos One|May 18, 2018
Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblastsJoshua Lee, Yusuke Echigoya, William Duddy, et al.
International Journal of Molecular Sciences|February 25, 2023
Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALSChristina Vasilopoulou, Sarah L McDaid-McCloskey, Gavin McCluskey, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Changes in Communication between Muscle Stem Cells and their Environment with AgingMatthew Thorley, Apostolos Malatras, William Duddy, et al.
Cells|March 10, 2022
The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger SubtypesEkene Anakor, Vanessa Milla, Owen Connolly, et al.
Frontiers in Neurology|May 30, 2019
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALSUdaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, et al.
Pageof 4